NPS Pharmaceuticals (NASDAQ: NPSP) today announced that its Chief Financial Officer, Luke M. Beshar, CPA, has been honored as New Jersey Public Company CFO of the Year by NJBIZ, New Jersey’s only weekly business journal covering the entire state.
“We’re all very proud of Luke,” said Francois Nader, MD, NPS Pharmaceuticals CEO. “Luke’s financial vision and leadership continue to significantly contribute to NPS' success and to the strengthening of our financial structure. This award is certainly a well-deserved honor. We are glad to see he is getting the recognition he deserves for his achievements here at NPS.”
Since Mr. Beshar became CFO in November 2007, NPS has secured nearly $150M of new capital. Mr. Beshar has reorganized and built a high-caliber finance team and established a disciplined financial planning and analysis function. With two drugs in Phase 3 development for orphan indications, a strong royalty-based portfolio of four commercial-stage assets, and a healthy balance sheet and solid financial runway, NPS is well-positioned to deliver a number of value-driving catalysts to its stakeholders over the next 12 to 15 months.
No comments:
Post a Comment